Literature DB >> 33545977

Value of anti-hepatitis B virus in serum tested by enzyme linked immunosorbent assay 3 in diagnosis of hepatitis B: A protocol for systemic review and meta analysis.

Shen Fei-Fei1, Ren Xiao-Dan2, Liu Hai-Qiang3, Zhang He-Wei4.   

Abstract

INTRODUCTION: This protocol is for a meta analysis that aims to systematically review the diagnostic value of anti-hepatitis B virus in serum tested by the enzyme linked immunosorbent assay in patients with hepatitis B. METHODS AND ANALYSIS: The following electronic databases will be searched from inception to Mar 2021: PubMed, Web of Science, ScienceDirect, EMBASE, MEDLINE, Springer, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Chinese Science and Technology Periodical Database, and Wanfang Database. All study about enzyme linked immunosorbent assay reagents have been published at home and abroad to diagnose hepatitis B virus will be included. MetaDisc 1.4 soft will used to calculate pooled effect size in sensitivity, specifi city, likelihood ratio, diagnostic odds ratio and summary receiver operating characteristic curve, and area under the curve as well. ETHICS AND DISSEMINATION: Formal ethical approval is not required, as the data are not individualized. The findings of this systematic review will be disseminated in a peer-reviewed publication and/or presented at relevant conferences. REGISTRATION NUMBER: INPLASY2020100051.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33545977      PMCID: PMC7837889          DOI: 10.1097/MD.0000000000023961

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  9 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

Authors:  J M Barrera; B Francis; G Ercilla; M Nelles; D Achord; J Darner; S R Lee
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

3.  Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.

Authors:  S Noppornpanth; N Sathirapongsasuti; V Chongsrisawat; Y Poovorawan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-06       Impact factor: 0.267

Review 4.  Hepatitis B: an important public health issue.

Authors:  W C Maddrey
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

Review 5.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Authors:  D Lavanchy
Journal:  J Viral Hepat       Date:  2004-03       Impact factor: 3.728

Review 6.  The global burden of liver disease: the major impact of China.

Authors:  Fu-Sheng Wang; Jian-Gao Fan; Zheng Zhang; Bin Gao; Hong-Yang Wang
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

Review 7.  Chronic hepatitis B virus infection.

Authors:  Wai-Kay Seto; Ying-Ru Lo; Jean-Michel Pawlotsky; Man-Fung Yuen
Journal:  Lancet       Date:  2018-11-24       Impact factor: 79.321

8.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

9.  Lung ultrasound for the diagnosis of pneumonia in adults: A meta-analysis.

Authors:  Ling Long; Hao-Tian Zhao; Zhi-Yang Zhang; Guang-Ying Wang; He-Ling Zhao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.